Go to deals
Healthcare

Grupo Auguri has acquired a controlling interest in Clínica Las Condes S.A.

Grupo Auguri has acquired a controlling interest in Clínica Las Condes S.A.

Grupo Auguri is a Chilean family office linked to the Karlezi Solari family, which have investments in multiple companies from various industries throughout the country and abroad.

Based in Santiago, Clínica Las Condes is one of the largest private hospitals in Chile. The company initiated its operations in 1982 with a focus on high complexity medicine. Its services include inpatient medical, surgical intensive care units, intermediate, adult, pediatric, neonatal, surgical wards, post-recovery operative, clinical laboratories, radiology, CT magnetic resonance imaging, radiation therapy, PET-CT, nuclear medicine, ultrasound, dialysis and other services that include outpatient procedures.

Oaklins’ team in Chile acted as financial advisor to Grupo Auguri in this transaction.

Service
M&A buy-side
Parties

Talk to the deal team

 Raimundo  Silva

Raimundo Silva

Partner

Santiago, Chile
Oaklins LarrainVial
 Alberto  del Pedregal

Alberto del Pedregal

Analyst

Santiago, Chile
Oaklins LarrainVial

Related deals

Pridiktiv has been acquired by Corilus
Healthcare | TMT

Pridiktiv has been acquired by Corilus

The shareholders and founders of Pridiktiv NV have sold the company to Corilus.

Learn more
Global Media Santé has been acquired by SFP Expansion
Private Equity | Healthcare | TMT

Global Media Santé has been acquired by SFP Expansion

Global Media Santé’s CEO, Alain Trébucq, and Apax Partners have sold the company to SFP Expansion Group.

Learn more
Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate
Healthcare

Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate

Synairgen plc has completed its oversubscribed equity fundraising to raise US$114 million to fund a Phase III trial for 900 patients for the effects of its SNG001 drug on patients with COVID-19. In addition the raise will be used to scale up manufacturing and device activities.

Learn more